{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T23:22:14Z","timestamp":1788391334458,"version":"build-2803163510"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>The 13-valent pneumococcal conjugate vaccine (PCV13) has been recommended in France since June 2010. The aim of this study was to evaluate the trends in the incidence of invasive pneumococcal disease (IPD) resulting in hospitalization of children younger than 18 years of age, to identify the vaccination status of these patients and to analyze the serotypic evolution of the pneumococci involved in the various types of IPD.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>This multicenter retrospective study reviewed all admissions of children younger than 18 years of age for IPD from 2014 through 2018 in all hospitals with a pediatric or neonatal unit in northern France. Data completeness was obtained by matching 3 independent databases. The incidence of IPD resulting in hospitalization was calculated per age group. The clinical course and the vaccine and nonvaccine types were described overall and by the IPD type.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>One hundred thirty cases of IPD were identified: 51 with bacteremia, 45 meningitis, 28 pneumonia or pleuropneumonia and 6 arthritis. The IPD incidence ranged from 2.4 to 3.0\/100,000 in children under 18 years of age (95% confidence intervals, 1.4\u20133.3 and 1.9\u20134.1, respectively), and from 9.5 to 15.9\/100,000 in children under 2 years of age, with no significant differences over time. Nonvaccine types were predominant (81%), mainly 24F, 23B and 10A. Vaccine serotype 3 was involved in 10 cases of IPD, 2 of which were in correctly vaccinated children. Two cases of IPD could have been prevented by vaccination. Neurologic sequelae affected 26% of these children (62% of those with meningitis). Six children died from IPD (5%).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>The incidence of IPD resulting in hospitalization remained stable in northern France during the study period, with no significant increase in nonvaccine types. Further surveillance is needed to adjust the vaccination strategy if necessary.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000003095","type":"journal-article","created":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T18:16:29Z","timestamp":1623089789000},"page":"688-693","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Stable Incidence of Invasive Pneumococcal Disease in Children in Northern France From 2014 Through 2018"],"prefix":"10.1097","volume":"40","author":[{"given":"Emilie","family":"Coronas","sequence":"first","affiliation":[{"name":"CHU Lille, Pediatric Emergency Unit and Infectious Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Martinot","sequence":"additional","affiliation":[{"name":"CHU Lille, Pediatric Emergency Unit and Infectious Diseases"},{"name":"University of Lille, ULR 2694\u2014METRICS: Evaluation des technologies de Sant\u00e9 et des pratiques m\u00e9dicales, Lille"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Varon","sequence":"additional","affiliation":[{"name":"Centre National de R\u00e9f\u00e9rence du Pneumocoque, Centre Hospitalier Intercommunal de Cr\u00e9teil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Wallet","sequence":"additional","affiliation":[{"name":"CHU Lille, Laboratory of bacteriology, Pathology-Biology Center, Lille, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Dubos","sequence":"additional","affiliation":[{"name":"CHU Lille, Pediatric Emergency Unit and Infectious Diseases"},{"name":"University of Lille, ULR 2694\u2014METRICS: Evaluation des technologies de Sant\u00e9 et des pratiques m\u00e9dicales, Lille"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,6,7]]},"reference":[{"key":"R1-20250615","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S1473-3099(14)70027-1","article-title":"Hospital admission rates for meningitis and septicaemia caused by Haemophilus influenzae, Neisseria meningitidis, and Streptococcus pneumoniae in children in England over five decades: a population-based observational study.","volume":"14","author":"Martin","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"R2-20250615","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/j.vaccine.2014.02.008","article-title":"Can the success of pneumococcal conjugate vaccines for the prevention of pneumococcal diseases in children be extrapolated to adults?","volume":"32","author":"Weil-Olivier","year":"2014","journal-title":"Vaccine"},{"key":"R3-20250615","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s00431-013-2260-8","article-title":"The burden of pneumococcal meningitis in Austrian children between 2001 and 2008.","volume":"173","author":"Klobassa","year":"2014","journal-title":"Eur J Pediatr"},{"key":"R4-20250615","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S1473-3099(04)00938-7","article-title":"Streptococcus pneumoniae colonisation: the key to pneumococcal disease.","volume":"4","author":"Bogaert","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"R5-20250615","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1093\/cid\/ciz221","article-title":"Changes in invasive pneumococcal disease spectrum after 13-valent pneumococcal conjugate vaccine implementation.","volume":"70","author":"Levy","year":"2020","journal-title":"Clin Infect Dis"},{"key":"R6-20250615","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1136\/adc.2007.119891","article-title":"Decline in pneumococcal meningitis after the introduction of the heptavalent-pneumococcal conjugate vaccine in northern France.","volume":"92","author":"Dubos","year":"2007","journal-title":"Arch Dis Child"},{"key":"R7-20250615","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1111\/j.1651-2227.2010.01914.x","article-title":"Rebound in the incidence of pneumococcal meningitis in northern France: effect of serotype replacement.","volume":"99","author":"Alexandre","year":"2010","journal-title":"Acta Paediatr"},{"key":"R8-20250615","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1017\/S095026881500179X","article-title":"Impact of the 13-valent pneumococcal conjugate vaccine on the incidence of pneumococcal meningitis in children.","volume":"144","author":"Chapoutot","year":"2016","journal-title":"Epidemiol Infect"},{"key":"R9-20250615","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1186\/s12879-015-1147-x","article-title":"Pneumococcal serotype evolution in Western Europe.","volume":"15","author":"Tin Tin Htar","year":"2015","journal-title":"BMC Infect Dis"},{"key":"R10-20250615","first-page":"2704","article-title":"Phenotypic characterization and antibiogram of CSF isolates in acute bacterial meningitis.","volume":"7","author":"Modi","year":"2013","journal-title":"J Clin Diagn Res"},{"key":"R11-20250615","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1016\/j.ijid.2009.05.010","article-title":"Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines.","volume":"14","author":"Isaacman","year":"2010","journal-title":"Int J Infect Dis"},{"key":"R12-20250615","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1080\/21645515.2016.1157239","article-title":"What timing of vaccination is potentially dangerous for children younger than 2 years?","volume":"12","author":"Gras","year":"2016","journal-title":"Hum Vaccine Immunother"},{"key":"R13-20250615","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.vaccine.2014.11.011","article-title":"Impact of the pneumococcal conjugate vaccines on invasive pneumococcal disease in France, 2001-2012.","volume":"33","author":"Lepoutre","year":"2015","journal-title":"Vaccine"},{"key":"R14-20250615","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1186\/s12879-019-4119-8","article-title":"The impact of childhood pneumococcal vaccination on hospital admissions in England: a whole population observational study.","volume":"19","author":"Shiri","year":"2019","journal-title":"BMC Infect Dis"},{"key":"R15-20250615","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/INF.0000000000002549","article-title":"Invasive streptococcus pneumoniae infections and vaccine failures in children in ireland from the postvaccine era from 2007 to 2018.","volume":"39","author":"Corcoran","year":"2020","journal-title":"Pediatr Infect Dis J"},{"key":"R16-20250615","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1016\/j.vaccine.2019.06.071","article-title":"Effectiveness of the seven-valent and thirteen-valent pneumococcal conjugate vaccines in England: the indirect cohort design, 2006-2018.","volume":"37","author":"Andrews","year":"2019","journal-title":"Vaccine"},{"key":"R17-20250615","doi-asserted-by":"crossref","first-page":"e0226353","DOI":"10.1371\/journal.pone.0226353","article-title":"The shifting epidemiology and serotype distribution of invasive pneumococcal disease in Ontario, Canada, 2007-2017.","volume":"14","author":"Wijayasri","year":"2019","journal-title":"PLoS One"},{"key":"R18-20250615","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.3201\/eid2407.180029","article-title":"Pediatric complicated pneumonia caused by streptococcus pneumoniae serotype 3 in 13-valent pneumococcal conjugate vaccinees, portugal, 2010-2015.","volume":"24","author":"Silva-Costa","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"R19-20250615","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/21645515.2015.1116654","article-title":"The multifaceted impact of pneumococcal conjugate vaccine implementation in children in France between 2001 to 2014.","volume":"12","author":"Cohen","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"R20-20250615","first-page":"pii","article-title":"Impact of the 13-valent pneumococcal conjugate vaccine on severe invasive disease caused by serotype 3 Streptococcus pneumoniae in Italian children.","volume":"7","author":"Lodi","year":"2019","journal-title":"Vaccines (Basel)"},{"key":"R21-20250615","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.3201\/eid2509.180747","article-title":"Effect of pneumococcal conjugate vaccines on pneumococcal Meningitis, England and Wales, July 1, 2000-June 30, 2016.","volume":"25","author":"Oligbu","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"R22-20250615","doi-asserted-by":"crossref","first-page":"e20190567","DOI":"10.1542\/peds.2019-0567","article-title":"Invasive pneumococcal disease in children\u2019s hospitals: 2014-2017.","volume":"144","author":"Kaplan","year":"2019","journal-title":"Pediatrics"},{"key":"R23-20250615","doi-asserted-by":"crossref","first-page":"6178","DOI":"10.1016\/j.vaccine.2015.10.015","article-title":"Invasive disease potential of pneumococci before and after the 13-valent pneumococcal conjugate vaccine implementation in children.","volume":"33","author":"Varon","year":"2015","journal-title":"Vaccine"},{"key":"R24-20250615","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.vaccine.2015.11.015","article-title":"Serotypes, antimicrobial susceptibility, and molecular epidemiology of invasive and non-invasive Streptococcus pneumoniae isolates in paediatric patients after the introduction of 13-valent conjugate vaccine in a nationwide surveillance study conducted in Japan in 2012-2014.","volume":"34","author":"Nakano","year":"2016","journal-title":"Vaccine"},{"key":"R25-20250615","first-page":"816","article-title":"Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"61","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R26-20250615","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1093\/jac\/dkv061","article-title":"Assessment of multidrug resistance, clonality and virulence in non-PCV-13 Streptococcus pneumoniae serotypes in Canada, 2011-13.","volume":"70","author":"Golden","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"R27-20250615","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.1038\/s41598-019-41983-8","article-title":"Molecular characterization and epidemiology of Streptococcus pneumoniae serotype 24F in Denmark.","volume":"9","author":"Kavalari","year":"2019","journal-title":"Sci Rep"},{"key":"R28-20250615","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s12879-015-0941-9","article-title":"Increase of serotypes 15A and 23B in IPD in Germany in the PCV13 vaccination era.","volume":"15","author":"van der Linden","year":"2015","journal-title":"BMC Infect Dis"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003095","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T16:02:23Z","timestamp":1750003343000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,7]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000003095","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6,7]]}}}